SYNOVUS FINANCIAL CORP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 61 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2022. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$50,516
-22.3%
58,0710.0%0.00%0.0%
Q2 2023$65,040
+7.7%
58,0710.0%0.00%0.0%
Q1 2023$60,394
-16.9%
58,071
-10.5%
0.00%0.0%
Q4 2022$72,634
-1.8%
64,8510.0%0.00%0.0%
Q3 2022$74,000
-22.1%
64,8510.0%0.00%0.0%
Q2 2022$95,000
-44.4%
64,851
-13.4%
0.00%
-50.0%
Q1 2022$171,000
+122.1%
74,851
+166.6%
0.00%
+100.0%
Q4 2021$77,000
-54.2%
28,0710.0%0.00%
-50.0%
Q3 2021$168,000
+23.5%
28,0710.0%0.00%
+100.0%
Q2 2021$136,000
+97.1%
28,0710.0%0.00%0.0%
Q1 2021$69,000
-10.4%
28,0710.0%0.00%0.0%
Q4 2020$77,000
+2466.7%
28,071
+461.4%
0.00%
Q3 2019$3,000
-40.0%
5,0000.0%0.00%
Q2 2019$5,000
-28.6%
5,0000.0%0.00%
Q1 2019$7,000
+40.0%
5,0000.0%0.00%
Q4 2018$5,000
-85.3%
5,000
-9.1%
0.00%
-100.0%
Q3 2018$34,000
-42.4%
5,5000.0%0.00%0.0%
Q2 2018$59,0000.0%5,5000.0%0.00%0.0%
Q1 2018$59,000
+110.7%
5,500
+57.1%
0.00%0.0%
Q1 2017$28,000
+115.4%
3,500
+133.3%
0.00%
Q4 2016$13,0001,5000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders